ResearcherNihon UniversityNo recent work listed

Mitsuhiko Moriyama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4617-508X; OpenAlex author ID A5055964691. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report. Co-author DOI 10.2169/internalmedicine.4456-20 ↗
Involvement of the Interferon Signaling Pathways in Pancreatic Cancer Cells. Last author DOI 10.21873/anticanres.14449 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kunio Iwatsuka · 1 shared paper, 2021 · strength 0.13
- Paper Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarc… DOI 10.2169/internalmedicine.4456-20 ↗
Kenji Yamao · 1 shared paper, 2021 · strength 0.13
- Paper Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarc… DOI 10.2169/internalmedicine.4456-20 ↗
Tadatoshi Takayama · 1 shared paper, 2020 · strength 0.10
- Paper Involvement of the Interferon Signaling Pathways in Pancreatic Cancer Cells. DOI 10.21873/anticanres.14449 ↗
Mariko Fujisawa · 1 shared paper, 2020 · strength 0.10
- Paper Involvement of the Interferon Signaling Pathways in Pancreatic Cancer Cells. DOI 10.21873/anticanres.14449 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.